CAF-derived extracellular matrix, cytokines, and growth factors reshape the tumor microenvironment through complementary effects. Matrix production remodels the surrounding tissue, while secreted cytokines and growth factors alter communication among tumor and stromal cells. Together, these activities can support angiogenesis, modify immune activity, and create conditions that favor tumor-cell invasion, linking stromal remodeling to cancer progression.
Resident fibroblasts can become involved when tumor-derived signals stimulate their activation, placing local stromal cells within the cancer-supporting environment. However, CAFs are not functionally uniform: their subtypes can differ in the activities they perform. This diversity means that CAF-related effects can vary among tumors and must be considered when interpreting stromal mechanisms or developing CAF-focused strategies.
By altering immune activity, CAFs can influence how surrounding immune responses operate within the tumor environment. At the same time, their effects on angiogenesis can change tissue conditions that support tumor growth. Considering both processes shows that CAF biology extends beyond tumor-cell behavior to coordinated changes in vascular and immune components surrounding the cancer.
CAF-driven tissue remodeling and signaling can influence how therapies encounter the tumor environment. Their association with treatment response and therapeutic resistance makes them relevant to understanding why cancer may respond incompletely. CAFs are therefore investigated as possible targets for improving drug delivery and strengthening treatment strategies, including approaches involving immunotherapy and precision cancer treatment.
CAFs are considered potential biomarkers because their subtypes and functions reflect biologically meaningful differences in the tumor microenvironment. Examining these differences may help researchers relate stromal features to disease development, treatment response, or therapeutic resistance. The same information can support precision-cancer strategies by identifying which stromal characteristics deserve closer experimental or clinical attention.
In cancer biology, CAF research connects the tumor cell to its surrounding tissue rather than treating disease as a tumor-cell-only process. CAF-focused studies can examine how stromal signals regulate progression, invasion, angiogenesis, immune activity, and therapy response. This broader view supports research aimed at improving immunotherapy, drug delivery, and precision treatment.